在慢性斑块性牛皮患者中由阿达利穆马布诱导的肝毒性:病例报告
Norah K Algarzae1, Hend M Alotaibi2, Ahmed H Alajlan2
1Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
International medical case reports journal
|July 15, 2025
概括
作为TNF-α对抗剂的阿达利穆马布可以导致肝损伤. 这一案例凸显了需要警的肝功能监测和迅速干预治疗阿达利姆巴的牛皮患者的需要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫皮肤学 免疫皮肤学
背景情况:
- 阿达利穆马布是一种针对瘤坏死因子-α (TNF-α) 的生物疗法.
- 它被广泛用于慢性斑块性牛皮和各种类风湿病.
- 虽然有效,但报告有罕见的肝毒性病例.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237
Chronic Pancreatitis I: Introduction
166
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
166
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
272
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
272


